[go: up one dir, main page]

WO2000052161A3 - Leukocyte- and blood-associated proteins - Google Patents

Leukocyte- and blood-associated proteins Download PDF

Info

Publication number
WO2000052161A3
WO2000052161A3 PCT/US2000/005153 US0005153W WO0052161A3 WO 2000052161 A3 WO2000052161 A3 WO 2000052161A3 US 0005153 W US0005153 W US 0005153W WO 0052161 A3 WO0052161 A3 WO 0052161A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood
lbap
associated proteins
leukocyte
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/005153
Other languages
French (fr)
Other versions
WO2000052161A2 (en
Inventor
Preeti Lal
Henry Yue
Jennifer L Hillman
Dyung Aina M Lu
Mariah R Baughn
Y Tom Tang
Yalda Azimzai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Priority to CA002363009A priority Critical patent/CA2363009A1/en
Priority to AU35068/00A priority patent/AU3506800A/en
Priority to JP2000602773A priority patent/JP2002537811A/en
Priority to EP00913665A priority patent/EP1157106A2/en
Publication of WO2000052161A2 publication Critical patent/WO2000052161A2/en
Publication of WO2000052161A3 publication Critical patent/WO2000052161A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention provides human leukocyte- and blood-associated proteins (LBAP) and polynucleotides which identify and encode LBAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of LBAP.
PCT/US2000/005153 1999-03-01 2000-02-29 Leukocyte- and blood-associated proteins Ceased WO2000052161A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002363009A CA2363009A1 (en) 1999-03-01 2000-02-29 Leukocyte- and blood-associated proteins
AU35068/00A AU3506800A (en) 1999-03-01 2000-02-29 Leukocyte- and blood-associated proteins
JP2000602773A JP2002537811A (en) 1999-03-01 2000-02-29 Leukocytes and blood-related proteins
EP00913665A EP1157106A2 (en) 1999-03-01 2000-02-29 Leukocyte- and blood-associated proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12208099P 1999-03-01 1999-03-01
US60/122,080 1999-03-01

Publications (2)

Publication Number Publication Date
WO2000052161A2 WO2000052161A2 (en) 2000-09-08
WO2000052161A3 true WO2000052161A3 (en) 2001-03-29

Family

ID=22400482

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/005153 Ceased WO2000052161A2 (en) 1999-03-01 2000-02-29 Leukocyte- and blood-associated proteins

Country Status (5)

Country Link
EP (1) EP1157106A2 (en)
JP (1) JP2002537811A (en)
AU (1) AU3506800A (en)
CA (1) CA2363009A1 (en)
WO (1) WO2000052161A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021658A1 (en) * 1999-09-24 2001-03-29 Human Genome Sciences, Inc. 32 human secreted proteins
AU7784700A (en) * 1999-09-30 2001-04-30 Smithkline Beecham Biologicals (Sa) Novel compounds
US20020081625A1 (en) * 1999-10-14 2002-06-27 John Ford Member of the immunoglobulin superfamily and uses thereof
CA2461065A1 (en) * 2001-09-19 2003-03-27 The Government Of The United States Of America Transductin-1 and transductin-2 and applications to hereditary deafness

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001301A1 (en) * 1986-08-13 1988-02-25 The General Hospital Corporation Detection marker for colonic lesions
EP0346710A2 (en) * 1988-06-16 1989-12-20 Miles Inc. cDNAs coding for members of the carcinoembryonic antigen family
US5861272A (en) * 1995-06-02 1999-01-19 Human Genome Sciences, Inc. C5A receptor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001301A1 (en) * 1986-08-13 1988-02-25 The General Hospital Corporation Detection marker for colonic lesions
EP0346710A2 (en) * 1988-06-16 1989-12-20 Miles Inc. cDNAs coding for members of the carcinoembryonic antigen family
US5861272A (en) * 1995-06-02 1999-01-19 Human Genome Sciences, Inc. C5A receptor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HILLIER ET AL.: "The washU-Merck EST Project", EMBL SEQUENCE DATABASE, 18 February 1996 (1996-02-18), HEIDELBERG DE, XP002147850 *
HILLIER ET AL.: "WashU-Merck EST project 1997", EMBL SEQUENCE DATABASE, 13 June 1997 (1997-06-13), HEIDELBERG DE, XP002147851 *

Also Published As

Publication number Publication date
AU3506800A (en) 2000-09-21
EP1157106A2 (en) 2001-11-28
JP2002537811A (en) 2002-11-12
WO2000052161A2 (en) 2000-09-08
CA2363009A1 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
WO2001012662A3 (en) Membrane associated proteins
WO1999061471A3 (en) Human transmembrane proteins
WO2000015793A3 (en) Human gpcr proteins
WO2000018922A3 (en) Human carbohydrate-associated proteins
WO2000034477A3 (en) Neuron-associated proteins
WO1999058692A3 (en) Human apoptosis associated proteins
WO2000009709A3 (en) Proteases and associated proteins
WO2001020004A3 (en) Protein phosphatase and kinase proteins
WO2000026245A3 (en) Human membrane transport proteins
WO2000012703A3 (en) Protein transport-associated molecules
WO2000017355A3 (en) Human cytoskeleton associated proteins
WO2001005970A3 (en) Gtp-binding protein associated factors
WO2000014251A3 (en) Human transferase proteins
WO2001007612A3 (en) Receptors and associated proteins
WO2000052151A3 (en) Human secretory proteins
WO2000078953A3 (en) Human transport proteins
WO2000044900A3 (en) Nucleic-acid binding proteins
WO2000056891A3 (en) Human transmembrane proteins
WO2001044448A3 (en) Human oxidoreductase proteins
WO2001096546A3 (en) Protein phosphatases
WO2000028045A3 (en) Human hydrolase proteins
WO2001085942A3 (en) Cytoskeleton-associated proteins
WO2000065054A3 (en) Human membrane-associated proteins
WO2000008155A3 (en) Human receptor-associated proteins
WO2000001821A3 (en) Neurotransmission associated proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2363009

Country of ref document: CA

Ref country code: CA

Ref document number: 2363009

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 602773

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000913665

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000913665

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09914815

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2000913665

Country of ref document: EP